• News
  • SAN DIEGO
  • Finance

Daily Digest

The Daily Digest intends to help readers track major announcements made by and about companies on the San Diego Stock Exchange Index. The Daily Digest tracks announcements and SEC filings released from midnight until 4 p.m., or three hours after the stock markets close. To see how companies on the San Diego Stock Exchange Index performed, visit sddt.com/stocks.

Acadia Pharmaceuticals Inc.: Company was rated new “neutral” by brokerage firm Piper Jaffray. The target price is $5 per share.

Alphatec Holdings Inc.: Company announced it has received FDA clearance for Pegasus interbody device and its ILLICO FS Facet Fixation system.

Callaway Golf Co.: Company announced its new line of X Hot Drivers and Fairway Woods, which will be available at golf shops nationwide starting on Jan. 25.

Entropic Communications: Company announced the unveiling of a new corporate logo, redesigned website and new message platform.

Halozyme Therapeutics Inc.: Company announced it will present at the 31st Annual JP Morgan Healthcare Conference, Jan. 10 in San Francisco.

Kratos Defense & Security Solutions Inc.: Company announced it will present at the 15th Annual Needham Growth Conference in New York City, Jan. 17.

Mad Catz Interactive Inc.: Company announced the launch of its new technology initiative, GameSmart.

Orexigen Therapeutics Inc.: Company was rated new “overweight” by brokerage firm Piper Jaffray. The target price is $10 per share.

Overland Storage Inc.: Company announced it will present at the Needham & Company 15th Annual Growth Conference, Jan. 15 in New York City.

Qualcomm Inc: SEC documents showed: Vice President James Lederer exercised options on 19,919 shares at $35.66 to $52.87 per share, and sold 19,919 shares at $63.58 per share on Wednesday; and Chairman of the Board Paul Jacobs exercised options on 92,000 shares at $35.66 to $37.29 per share, and sold 92,000 shares at $63.69 to $64.11 per share on Wednesday.

Quidel Corp: Company announced it will present at the 31st Annual JP Morgan Healthcare Conference, Jan. 9 in San Francisco.

Somaxon Pharmaceuticals Inc.: SEC documents showed CFO Tran Nguyen sold 412 shares at $3.08 per share on Wednesday.

TearLab Corp.: Company was rated new “strong buy” by brokerage firm Feltl. The target price is $7 per share.

Vical Inc.: Company announced it will present at the 2013 JP Morgan Healthcare Conference, Jan. 10 in San Francisco.

WD-40 Co: Company announced it will report first quarter financial results Jan. 8, after the market closes.

User Response
0 UserComments